JAMA Ophthalmology Author Interviews
by JAMA NetworkInterviews with authors of articles from JAMA Ophthalmology. JAMA Ophthalmology, published continuously since 1869, is an international, peer-reviewed ophthalmology and visual science journal. Covering research, science, & clinical practice in ophthalmology and vision science.
Copyright: American Medical Association, 2020
Episodes
Automated Machine Learning for Predicting DR Progression From Ultra-Widefield Retinal Images
13m · PublishedInterview with Paolo S. Silva, MD, and Jennifer K. Sun, MD, MPH, authors Automated Machine Learning for Predicting Diabetic Retinopathy Progression From Ultra-Widefield Retinal Images. Hosted by Neil M. Bressler, MD.
Related Content:
- Automated Machine Learning for Predicting Diabetic Retinopathy Progression From Ultra-Widefield Retinal Images
Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening
15m · PublishedInterview with Sophia Y. Wang, MD, MS, author of Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening. Hosted by Neil Bressler, MD.
Related Content:
- Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening
Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion
16m · PublishedInterview with Prithvi Mruthyunjaya, MD, MHS, author of Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. Hosted by Neil M. Bressler, MD.
Related Content:
- Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion
Assessing Strategies to Reduce Carbon Footprint of the AAO Annual Meeting
17m · PublishedInterview with Scott M. McClintic, MD, author of Assessing Strategies to Reduce the Carbon Footprint of the Annual Meeting of the American Academy of Ophthalmology. Hosted by Neil Bressler, MD.
Related Content:
- Assessing Strategies to Reduce the Carbon Footprint of the Annual Meeting of the American Academy of Ophthalmology
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
13m · PublishedInterview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
- Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
Predictive Value of Parafoveal Diabetic Macular Ischemia for Diabetic Retinal Disease Progression and VA Deterioration
16m · PublishedInterview with Carol Y. Cheung, PhD, author of Assessment of Parafoveal Diabetic Macular Ischemia on Optical Coherence Tomography Angiography Images to Predict Diabetic Retinal Disease Progression and Visual Acuity Deterioration. Hosted by Neil Bressler, MD.
Related Content:
- Assessment of Parafoveal Diabetic Macular Ischemia on Optical Coherence Tomography Angiography Images to Predict Diabetic Retinal Disease Progression and Visual Acuity Deterioration
Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination
15m · PublishedInterview with Rishi P. Singh, MD, author of Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data. Hosted by Neil Bressler, MD.
Related Content:
- Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data
Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the IRIS Registry
14m · PublishedInterview with Isdin Oke, MD, author of Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry. Hosted by Neil Bressler, MD.
Related Content:
- Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry
Incidence of Glaucoma-Related Adverse Events Following Pediatric Lensectomy
20m · PublishedInterview with Erick D. Bothun, MD, author of Incidence of Glaucoma-Related Adverse Events in the First 5 Years After Pediatric Lensectomy. Hosted by Neil Bressler, MD.
Related Content:
- Incidence of Glaucoma-Related Adverse Events in the First 5 Years After Pediatric Lensectomy
Cost-effectiveness of Aflibercept vs Bevacizumab-First Therapy for Diabetic Macular Edema
13m · PublishedInterview with David W. Hutton, PhD, author of Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema. Hosted by Neil Bressler, MD.
JAMA Ophthalmology Author Interviews has 100 episodes in total of non- explicit content. Total playtime is 20:16:32. The language of the podcast is English. This podcast has been added on November 27th 2022. It might contain more episodes than the ones shown here. It was last updated on April 23rd, 2024 23:18.
